tiprankstipranks
Trending News
More News >
Nexam Chemical Holding AB (SE:NEXAM)
:NEXAM

Nexam Chemical Holding AB (NEXAM) AI Stock Analysis

Compare
0 Followers

Top Page

SE:NEXAM

Nexam Chemical Holding AB

(NEXAM)

Select Model
Select Model
Select Model
Neutral 46 (OpenAI - 5.2)
Rating:46Neutral
Price Target:
kr2.50
▲(6.38% Upside)
The score is held back primarily by ongoing losses and weak/volatile cash generation despite strong recent revenue growth and a conservatively financed balance sheet. Technicals are bearish with the price below key moving averages and negative MACD, and valuation is constrained by a negative P/E and no dividend yield.
Positive Factors
Strong TTM revenue growth
A 71.7% TTM revenue rebound signals durable commercial traction for Nexam's specialty polymer products. Sustained top-line growth supports scaling production, strengthens customer relationships and provides runway to invest in R&D and commercialization over the next several quarters.
Conservative balance sheet / low leverage
Very low debt-to-equity (~0.15) gives the company financial flexibility and resilience. Limited interest burden reduces cash drain, enabling management to fund development, absorb cyclical shocks, and pursue strategic partnerships or selective investment without urgent refinancing risk.
Specialty-chemicals model with collaborations
Nexam’s focus on crosslinkers and additives for automotive, electronics and packaging, plus long-term supply agreements and research collaborations, creates durable B2B ties. These relationships drive recurring demand, co-developed products and potential licensing revenues over medium term.
Negative Factors
Recurring negative profitability
Persistent negative EBIT and net income indicate the company is not yet converting revenue into sustainable profits. Continued losses erode retained earnings, may force dilutive financing, and constrain reinvestment capacity, raising execution risk over the coming quarters.
Very small, volatile free cash flow
Free cash flow remains minimal and has fallen materially year-over-year despite positive operating cash flow in the TTM. Limited and volatile FCF restricts the firm’s ability to fund capex, scale manufacturing or weather setbacks without external capital over 2–6 months.
Deteriorating gross margins
A ~11 percentage-point decline in gross margin suggests pricing pressure, higher input costs, or mix shifts that weaken unit economics. Margin erosion reduces operating leverage from revenue growth, making it harder to achieve sustainable profitability without efficiency or pricing improvements.

Nexam Chemical Holding AB (NEXAM) vs. iShares MSCI Sweden ETF (EWD)

Nexam Chemical Holding AB Business Overview & Revenue Model

Company DescriptionNexam Chemical Holding AB (publ) develops solutions that enhance properties and performance of various polymers in Sweden, Europe and internationally. It provides various products that enhance the properties and durability of polyesters, polyethylene, polyamides, polyimides, and high temperature resins, as well as produces various functional chemicals, additive/functional masterbatches, and color masterbatches and compounds under the NEXAMITE and NEXIMID names; and polymer recycling and reactive recycling solutions. The company serves aerospace, electronics, pipes, and engineered foams industries. Nexam Chemical Holding AB (publ) was founded in 2009 and is headquartered in Lomma, Sweden.
How the Company Makes MoneyNexam Chemical generates revenue primarily through the sale of its specialty chemicals and polymer solutions to a diverse range of industries. The company's revenue model is centered around the development and commercialization of innovative chemical products that meet specific customer needs. Key revenue streams include direct sales of products, long-term supply agreements with major industry players, and collaborative partnerships for research and development projects. Nexam also benefits from strategic collaborations with other companies and research institutions, which can provide additional funding and resources for product development. Furthermore, the company may engage in licensing agreements for its proprietary technology, contributing to its overall earnings.

Nexam Chemical Holding AB Financial Statement Overview

Summary
Nexam Chemical Holding AB displays a mixed financial performance with challenges in profitability and revenue growth. The balance sheet strength offers some comfort with a solid equity base and low leverage, but ongoing difficulties in cash flow stability and profitability are concerning.
Income Statement
Nexam Chemical Holding AB has experienced revenue fluctuations with a decline from 2022 to TTM (Trailing-Twelve-Months) and a slight decline in gross profit margins. The company has consistently reported negative net income and EBIT margins, indicating ongoing profitability challenges. However, EBITDA margin slightly improved in the TTM, showing some operational efficiencies.
Balance Sheet
The balance sheet reflects a solid equity base with a moderate debt-to-equity ratio. However, the declining trend in stockholders' equity and total assets over recent periods suggests potential risks in financial stability. The equity ratio remains strong, indicating a low level of leverage, which is a positive aspect of financial health.
Cash Flow
Cash flow analysis shows an improvement in free cash flow from negative to positive in the TTM, reflecting better cash management. However, operating cash flow has been inconsistent, and the operating cash flow to net income ratio is not strong, indicating challenges in converting profits into cash.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue197.72M199.58M190.28M221.76M219.45M165.83M
Gross Profit68.72M92.40M81.79M86.73M84.48M70.95M
EBITDA5.92M10.52M-5.01M780.00K6.30M5.08M
Net Income-14.33M-9.01M-22.84M-12.71M-5.46M-8.09M
Balance Sheet
Total Assets233.74M231.13M245.81M278.10M284.35M250.28M
Cash, Cash Equivalents and Short-Term Investments10.88M2.88M9.06M22.88M63.60M29.79M
Total Debt26.22M23.10M26.15M31.84M27.72M40.29M
Total Liabilities60.58M47.82M52.75M62.48M56.28M63.09M
Stockholders Equity173.16M183.31M193.06M215.62M228.06M187.18M
Cash Flow
Free Cash Flow313.00K-2.47M-9.53M-44.22M516.00K-23.45M
Operating Cash Flow7.26M7.43M-352.00K-11.10M7.19M-16.85M
Investing Cash Flow-9.41M-9.71M-9.18M-33.12M-6.25M-6.60M
Financing Cash Flow-1.60M-3.06M-5.17M3.85M33.23M30.05M

Nexam Chemical Holding AB Technical Analysis

Technical Analysis Sentiment
Negative
Last Price2.35
Price Trends
50DMA
3.00
Negative
100DMA
3.37
Negative
200DMA
3.49
Negative
Market Momentum
MACD
-0.22
Positive
RSI
39.13
Neutral
STOCH
35.24
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:NEXAM, the sentiment is Negative. The current price of 2.35 is below the 20-day moving average (MA) of 2.89, below the 50-day MA of 3.00, and below the 200-day MA of 3.49, indicating a bearish trend. The MACD of -0.22 indicates Positive momentum. The RSI at 39.13 is Neutral, neither overbought nor oversold. The STOCH value of 35.24 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:NEXAM.

Nexam Chemical Holding AB Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
48
Neutral
kr237.37M-3.55-57.89%91.07%
46
Neutral
kr190.15M-13.84-7.96%-1.89%-59.17%
45
Neutral
kr199.11M-6.50-75.16%-18.29%-48.74%
44
Neutral
kr130.64M-7.00-30.10%114.57%53.86%
44
Neutral
kr57.30M-4.24
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SE:NEXAM
Nexam Chemical Holding AB
2.45
-1.41
-36.53%
SE:AXIC.A
aXichem AB Class A
2.18
0.92
72.33%
SE:ORGC
OrganoClick AB
1.73
-1.22
-41.45%
SE:XPC
XP Chemistries AB
0.18
0.11
156.34%
SE:FERRO
Ferroamp AB
2.01
-1.29
-39.15%
SE:CINIS
Cinis Fertilizer AB
0.08
-5.10
-98.42%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 13, 2026